Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal use of quercetin-3-0-beta-D-glucancoside

A technology of glucoside and quercetin, which is applied in the field of new medical uses of known substances, can solve problems such as unseen cardiovascular and cerebrovascular diseases, and achieve the effects of reliable curative effect, high extraction cost and low extraction cost.

Inactive Publication Date: 2012-08-15
周亚球 +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] According to reports in the literature, quercetin-3-O-β-D-glucoside has the pharmacological effects of lowering blood pressure, protecting the liver, lowering enzymes, and analgesia, but so far there has been no report about its use in the prevention and treatment of cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal use of quercetin-3-0-beta-D-glucancoside
  • Medicinal use of quercetin-3-0-beta-D-glucancoside
  • Medicinal use of quercetin-3-0-beta-D-glucancoside

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Example 1: Synthesis of quercetin-3-O-β-D-glucoside

[0061] 1. Preparation of 7,3',4'-tri-O-benzyl quercetin

[0062] Rutin was dried under vacuum at 100°C for 6 hours to remove three crystal waters. Under the protection of N2, the dried rutin (2.44g) was dissolved in 20ml of anhydrous DMF, 1.83g of K2CO3 was added, after stirring for 1h, 1.6ml of freshly steamed benzyl bromide was slowly added dropwise, and then reacted at 40°C for 3h. The pH of the reaction solution was adjusted to 6 with 10% acetic acid in an ice bath, then 30 ml of distilled water was added thereto, the supernatant was discarded by centrifugation, and benzylated rutin was precipitated. Add 60ml of ethanol and 9ml of hydrochloric acid to the precipitate, and slowly heat to 70°C to completely dissolve the solid. After 10 minutes, a precipitate begins to precipitate in the solution, and the reaction ends after 2 hours. The reaction solution was cooled in an ice bath, and the precipitate was filtered...

Embodiment 2

[0069] Example 2: Quercetin-3-O-β-D-glucoside lyophilized powder for injection

[0070] Preparation of powder injection preparation (1):

[0071] Component Quantity

[0072] Quercetin-3-O-β-D-glucoside 5-50g

[0073] Tween 80 120g

[0074] Activated carbon 4g

[0075] Mannitol 400g

[0076] Poloxamer 8g

[0077] Quercetin-3-O-β-D-glucoside dry powder, Tween, poloxamer, melt it into a mortar and grind it to make it fully dispersed, add fresh water for injection saturated with carbon dioxide to 3500ml, add manna For alcohol, add activated carbon for needles in a water bath (50-70°C), stir while adding, boil for 5-10 minutes, cool to 40°C and filter through a vertical fusing filter. Dilute it with fresh water for injection to 4000ml, measure the pH and pass the content, pass through a 0.45um membrane, then pass through a 0.22um membrane, fill in 1000 vials, pre-freeze, and freeze to obtain 5-50mg of quercetin per bottle -3-O-β-D-glucoside lyophilized powder.

[0078] Prep...

Embodiment 3

[0079] Embodiment 3: quercetin-3-O-β-D-glucoside injection

[0080] Preparation of injection preparations (1)

[0081] Component Quantity

[0082] Quercetin-3-O-β-D-glucoside 5-50g

[0083] Sodium bicarbonate 22g

[0084] Sodium Metabisulfite 2g

[0085] Water for injection 1000ml

[0086] Take 1000ml of water for injection, boil, cool to room temperature, and set aside. Take 20% water for injection according to the prescription, add quercetin-3-O-β-D-glucoside to dissolve, slowly add sodium bicarbonate in stages and keep stirring, when there are no bubbles on the liquid surface, add coke Dissolve sodium sulfite, add the remaining water for injection to the full amount. Use a pH meter to measure the pH value of the medicinal solution and it should be 5.5-8.0. If it is not within this range, it can be adjusted with sodium bicarbonate. The medicinal liquid is filtered with a No. 3 vertical fusing glass filter until clear, filled with 500 ampoules, and sterilized at 100°C ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of the quercetol-3-0-beta-D-glucoside in preparing the medicines for treating cerebral anoxia and ischemia, and thrombosis is disclosed. Said quercetol-3- 0-beta-D-glucoside is prepared from rutine by semi-synthesis method with high output.

Description

1. Technical field: [0001] The present invention relates to a new medical application of a known substance, specifically the application of quercetin-3-O-β-D-glucoside in medicine for treating heart and brain ischemic diseases. 2. Background technology: [0002] Safflower (Flos Carthami) is a commonly used traditional Chinese medicine. It has the effects of promoting blood circulation, promoting menstruation, removing blood stasis and relieving pain. It has been clinically used in the prevention and treatment of cardiovascular and cerebrovascular diseases; Disease prevention and treatment. Analyzing their chemical composition, they all contain quercetin-3-O-β-D-glucoside. In 1995, Hang Lijun et al. reported "Studies on the Chemical Constituents of Chinese Medicine Safflower" in Modern Applied Pharmacy 12 (2): 19 (1995). They isolated quercetin-3-O-β from the dried flower extract of safflower -D-glucoside and other 8 kinds of flavonoid components. In 1992, A.Hasler and O.S...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P9/10A61P7/02
Inventor 王先荣周亚球陈磊
Owner 周亚球
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products